← Leaderboards
Jennifer Y. Chen
University Of California, San Francisco
$3,292,676
Attributed
$3,292,676
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $775.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,292,676 · 5
By mechanism
R01$1,865,204 · 1
K08$1,057,200 · 1
R03$242,250 · 1
P30$65,956 · 1
F32$62,066 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Peter Kent Jackson$14,452,290
- Graeme W Davis$30,172,967
- Hyunil Jo$2,065,344
- Kira Poskanzer$3,832,800
- Jonathan Koff$2,766,341
Others in their field
Top investigators on “Mission”
- Kelly K Wismer · Department Of Defense$358,750,224
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$333,898,233
- Michael E Cheney · Department Of Defense$330,315,072
- David Heimbrook · Leidos Biomedical Research, Inc.$325,587,550
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
MissionMolecularFibrosisLifeChronic Liver DiseasePathway InteractionsDisease ProgressionHepatic Stellate CellLiver FibrosisHepatic FibrogenesisIn VivoFibrogenesisLiver FailureCeramidesSignal PathwayGalactosylgalactosylglucosylceramidaseMediatingNovel TherapeuticsPublic HealthSignal TransductionUnited States National Institutes Of HealthExtracellular MatrixPreventCells
Grant awards (15)
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis$604,327
R01 · FY2025 · DK · contact PI
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis$104,973
R01 · FY2025 · DK · contact PI
Enrichment Program$65,956
P30 · FY2025 · DK · contact PI
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis$548,064
R01 · FY2024 · DK · contact PI
Role of PRKC alpha in Extracellular Matrix Remodeling$78,730
R01 · FY2024 · DK · contact PI
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis$529,110
R01 · FY2023 · DK · contact PI
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis$121,125
R03 · FY2023 · DK · contact PI
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis$121,125
R03 · FY2022 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$183,600
K08 · FY2021 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$137,700
K08 · FY2021 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$183,600
K08 · FY2020 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$183,600
K08 · FY2019 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$183,600
K08 · FY2018 · DK · contact PI
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis$185,100
K08 · FY2017 · DK · contact PI
Tricyclic Antidepressants Induce Hepatic Stellate Cell Quiescence: Identification of Mechanisms to Halt Hepatic Fibrosis$62,066
F32 · FY2015 · DK · contact PI